Corrigendum to “Apelin-13 impedes foam cells formation by activating ClassIIIPI3K/Beclin mediated autophagic pathway” (Apelin-13 impedes foam cell formation by activating Class III PI3K/Beclin-1-mediated autophagic pathway (2015) 466(4) (637–643), (S0006291X15305623), (10.1016/j.bbrc.2015.09.045));Apelin-13 impedes foam cell formation by activating Class III PI3K/Beclin-1-mediated autophagic pathway

Biochemical and Biophysical Research Communications

Volumn 466, Issue 4, 2015, Pages 637-643

  Yao, Feng ^a   Lv, Yun Cheng ^a   Zhang, Min ^a   Xie, Wei ^a   Tan, Yu Lin ^a   Gong, Duo ^a   Cheng, Hai Peng ^a   Liu, Dan ^a   Li, Liang ^a   Liu, Xiao Yan ^a   Zheng, Xi Long ^b   Tang, Chao Ke ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Apelin 13; Autophagy; Cholesterol efflux; Class III PI3K Beclin 1; Macrophage foam cells

Indexed keywords

APELIN; APELIN 13; BECLIN 1; CHOLESTEROL; ENZYME ACTIVATOR; LIPID; PHOSPHATIDYLINOSITOL 3 KINASE; RAPAMYCIN; UNCLASSIFIED DRUG; VINBLASTINE; ADIPOCYTOKINE; APELIN-13 PEPTIDE; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; FOAM CELL; HUMAN; HUMAN CELL; LIPID STORAGE; MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; THP 1 MACROPHAGE; ATHEROSCLEROSIS; BIOLOGICAL MODEL; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENZYME ACTIVATION; LIPID METABOLISM; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADIPOKINES; APOPTOSIS REGULATORY PROTEINS; ATHEROSCLEROSIS; AUTOPHAGY; CELL LINE; CHOLESTEROL; CLASS III PHOSPHATIDYLINOSITOL 3-KINASES; ENZYME ACTIVATION; FOAM CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; MACROPHAGES; MEMBRANE PROTEINS; MODELS, BIOLOGICAL;

EID: 84943260528     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2021.08.016     Document Type: Erratum

References (37)

1. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
2. X.H. Yu, Y.C. Fu, D.W. Zhang, K. Yin, and C.K. Tang Foam cells in atherosclerosis Clin. Chim. Acta 424 2013 245 252
3. R.S. Rosenson, H.B. Brewer Jr., W.S. Davidson, Z.A. Fayad, V. Fuster, J. Goldstein, M. Hellerstein, X.C. Jiang, M.C. Phillips, D.J. Rader, A.T. Remaley, G.H. Rothblat, A.R. Tall, and L. Yvan-Charvet Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport Circulation 125 2012 1905 1919
4. J.F. Wu, Y. Wang, M. Zhang, Y.Y. Tang, B. Wang, P.P. He, Y.C. Lv, X.P. Ouyang, F. Yao, Y.L. Tan, S.L. Tang, D.P. Tang, F.S. Cayabyab, X.L. Zheng, D.W. Zhang, G.F. Zeng, and C.K. Tang Growth differentiation factor-15 induces expression of ATP-binding cassette transporter A1 through PI3-K/PKCzeta/SP1 pathway in THP-1 macrophages Biochem. Biophys. Res. Commun. 444 2014 325 331
5. Y.W. Hu, Q. Wang, X. Ma, X.X. Li, X.H. Liu, J. Xiao, D.F. Liao, J. Xiang, and C.K. Tang TGF-beta1 up-regulates expression of ABCA1, ABCG1 and SR-BI through liver X receptor alpha signaling pathway in THP-1 macrophage-derived foam cells J. Atheroscler. Thromb. 17 2010 493 502
6. X.R. Hao, D.L. Cao, Y.W. Hu, X.X. Li, X.H. Liu, J. Xiao, D.F. Liao, J. Xiang, and C.K. Tang IFN-gamma down-regulates ABCA1 expression by inhibiting LXRalpha in a JAK/STAT signaling pathway-dependent manner Atherosclerosis 203 2009 417 428
7. Z.C. Mo, J. Xiao, S.L. Tang, X.P. Ouyang, P.P. He, Y.C. Lv, Z.F. Long, F. Yao, Y.L. Tan, W. Xie, M. Zhang, D. Liu, G.P. Tian, D.P. Tang, X.L. Zheng, G.J. Zhao, and C.K. Tang Advanced oxidation protein products exacerbates lipid accumulation and atherosclerosis through downregulation of ATP-binding cassette transporter A1 and G1 expression in apolipoprotein E knockout mice Circ. J. 78 2014 2760 2770
8. Y. Wang, J.F. Wu, Y.Y. Tang, M. Zhang, Y. Li, K. Chen, M.Y. Zeng, F. Yao, W. Xie, X.L. Zheng, G.F. Zeng, and C.K. Tang Urotensin II increases foam cell formation by repressing ABCA1 expression through the ERK/NF-kappaB pathway in THP-1 macrophages Biochem. Biophys. Res. Commun. 452 2014 998 1003
9. H. Fu, Y.Y. Tang, X.P. Ouyang, S.L. Tang, H. Su, X. Li, L.P. Huang, M. He, Y.C. Lv, P.P. He, F. Yao, Y.L. Tan, W. Xie, M. Zhang, J. Wu, Y. Li, K. Chen, D. Liu, G. Lan, M.Y. Zeng, X.L. Zheng, and C.K. Tang Interleukin-27 inhibits foam cell formation by promoting macrophage ABCA1 expression through JAK2/STAT3 pathway Biochem. Biophys. Res. Commun. 452 2014 881 887
10. S. Lavandero, R. Troncoso, B.A. Rothermel, W. Martinet, J. Sadoshima, and J.A. Hill Cardiovascular autophagy: concepts, controversies and perspectives Autophagy 9 2013
11. D. Gatica, M. Chiong, S. Lavandero, and D.J. Klionsky Molecular mechanisms of autophagy in the cardiovascular system Circ. Res. 116 2015 456 467
12. Y. Feng, D. He, Z. Yao, and D.J. Klionsky The machinery of macroautophagy Cell Res. 24 2014 24 41
13. R. Singh, S. Kaushik, Y. Wang, Y. Xiang, I. Novak, M. Komatsu, K. Tanaka, A.M. Cuervo, and M.J. Czaja Autophagy regulates lipid metabolism Nature 458 2009 1131 1135
14. K. Liu, and M.J. Czaja Regulation of lipid stores and metabolism by lipophagy Cell Death Differ. 20 2013 3 11
15. M. Ouimet, V. Franklin, E. Mak, X. Liao, I. Tabas, and Y.L. Marcel Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase Cell Metab. 13 2011 655 667
16. M.C. Maiuri, G. Grassia, A.M. Platt, R. Carnuccio, A. Ialenti, and P. Maffia Macrophage autophagy in atherosclerosis Mediat. Inflamm. 2013 2013 584715
17. H.J. Chun, Z.A. Ali, Y. Kojima, R.K. Kundu, A.Y. Sheikh, R. Agrawal, L. Zheng, N.J. Leeper, N.E. Pearl, A.J. Patterson, J.P. Anderson, P.S. Tsao, M.J. Lenardo, E.A. Ashley, and T. Quertermous Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis J. Clin. Invest. 118 2008 3343 3354
18. S.L. Pitkin, J.J. Maguire, R.E. Kuc, and A.P. Davenport Modulation of the apelin/APJ system in heart failure and atherosclerosis in man Br. J. Pharmacol. 160 2010 1785 1795
19. X.Y. Liu, Q. Lu, X.P. Ouyang, S.L. Tang, G.J. Zhao, Y.C. Lv, P.P. He, H.J. Kuang, Y.Y. Tang, Y. Fu, D.W. Zhang, and C.K. Tang Apelin-13 increases expression of ATP-binding cassette transporter A1 via activating protein kinase C alpha signaling in THP-1 macrophage-derived foam cells Atherosclerosis 226 2013 398 407
20. H.J. Bao, L. Zhang, W.C. Han, and D.K. Dai Apelin-13 attenuates traumatic brain injury-induced damage by suppressing autophagy Neurochem. Res. 40 2015 89 97
21. F. Xie, W. Liu, F. Feng, X. Li, L. Yang, D. Lv, X. Qin, L. Li, and L. Chen A static pressure sensitive receptor APJ promote H9c2 cardiomyocyte hypertrophy via PI3K-autophagy pathway Acta Biochim. Biophys. Sin. (Shanghai) 46 2014 699 708
22. A.F. Ceylan-Isik, M.R. Kandadi, X. Xu, Y. Hua, A.J. Chicco, J. Ren, and S. Nair Apelin administration ameliorates high fat diet-induced cardiac hypertrophy and contractile dysfunction J. Mol. Cell. Cardiol. 63 2013 4 13
23. C.K. Tang, G.H. Tang, G.H. Yi, Z. Wang, L.S. Liu, S. Wan, Z.H. Yuan, X.S. He, J.H. Yang, C.G. Ruan, and Y.Z. Yang Effect of apolipoprotein A-I on ATP binding cassette transporter A1 degradation and cholesterol efflux in THP-1 macrophage-derived foam cells Acta Biochim. Biophys. Sin. (Shanghai) 36 2004 218 226
24. M. Zhang, J.F. Wu, W.J. Chen, S.L. Tang, Z.C. Mo, Y.Y. Tang, Y. Li, J.L. Wang, X.Y. Liu, J. Peng, K. Chen, P.P. He, Y.C. Lv, X.P. Ouyang, F. Yao, D.P. Tang, F.S. Cayabyab, D.W. Zhang, X.L. Zheng, G.P. Tian, and C.K. Tang MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages Atherosclerosis 234 2014 54 64
25. D. Lv, H. Li, and L. Chen Apelin and APJ, a novel critical factor and therapeutic target for atherosclerosis Acta Biochim. Biophys. Sin. (Shanghai) 45 2013 527 533
26. A.M. Tycinska, A. Lisowska, W.J. Musial, and B. Sobkowicz Apelin in acute myocardial infarction and heart failure induced by ischemia Clin. Chim. Acta 413 2012 406 410
27. C. Galanth, A. Hus-Citharel, B. Li, and C. Llorens-Cortes Apelin in the control of body fluid homeostasis and cardiovascular functions Curr. Pharm. Des. 18 2012 789 798
28. R.A. Weir, K.S. Chong, J.R. Dalzell, C.J. Petrie, C.A. Murphy, T. Steedman, P.B. Mark, T.A. McDonagh, H.J. Dargie, and J.J. McMurray Plasma apelin concentration is depressed following acute myocardial infarction in man Eur. J. Heart Fail 11 2009 551 558
29. Z. Li, Y. Bai, and J. Hu Reduced apelin levels in stable angina Intern. Med. 47 2008 1951 1955
30. I. Tasci, T. Dogru, I. Naharci, G. Erdem, M.I. Yilmaz, A. Sonmez, N. Bingol, S. Kilic, S. Bingol, and S. Erikci Plasma apelin is lower in patients with elevated LDL-cholesterol Exp. Clin. Endocrinol. Diabetes 115 2007 428 432
31. I. Tasci, G. Erdem, G. Ozgur, S. Tapan, T. Dogru, H. Genc, C. Acikel, T. Ozgurtas, and A. Sonmez LDL-cholesterol lowering increases plasma apelin in isolated hypercholesterolemia Atherosclerosis 204 2009 222 228
32. W. Martinet, and G.R. De Meyer Autophagy in atherosclerosis Curr. Atheroscler. Rep. 10 2008 216 223
33. D.M. Schrijvers, G.R. De Meyer, and W. Martinet Autophagy in atherosclerosis: a potential drug target for plaque stabilization Arterioscler. Thromb. Vasc. Biol. 31 2011 2787 2791
34. I. Perrotta The use of electron microscopy for the detection of autophagy in human atherosclerosis Micron 50 2013 7 13
35. C. He, and D.J. Klionsky Regulation mechanisms and signaling pathways of autophagy Annu. Rev. Genet. 43 2009 67 93
36. A. Kihara, Y. Kabeya, Y. Ohsumi, and T. Yoshimori Beclin-phosphatidylinositol 3-kinase complex functions at the trans-Golgi network EMBO Rep. 2 2001 330 335
37. S. Pattingre, A. Tassa, X. Qu, R. Garuti, X.H. Liang, N. Mizushima, M. Packer, M.D. Schneider, and B. Levine Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 122 2005 927 939